Log in to save to my catalogue

T cell costimulation, checkpoint inhibitors and anti-tumor therapy

T cell costimulation, checkpoint inhibitors and anti-tumor therapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2489441108

T cell costimulation, checkpoint inhibitors and anti-tumor therapy

About this item

Full title

T cell costimulation, checkpoint inhibitors and anti-tumor therapy

Publisher

New Delhi: Springer India

Journal title

Journal of biosciences, 2020-12, Vol.45 (1), p.50-50, Article 50

Language

English

Formats

Publication information

Publisher

New Delhi: Springer India

More information

Scope and Contents

Contents

The hallmarks of the adaptive immune response are specificity and memory. The cellular response is mediated by T cells which express cell surface T cell receptors (TCRs) that recognize peptide antigens in complex with major histocompatibility complex (MHC) molecules on antigen presenting cells (APCs). However, binding of cognate TCRs with MHC-pepti...

Alternative Titles

Full title

T cell costimulation, checkpoint inhibitors and anti-tumor therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2489441108

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2489441108

Other Identifiers

ISSN

0250-5991,0973-7138

E-ISSN

0973-7138

DOI

10.1007/s12038-020-0020-2

How to access this item